Added to YB: 2024-06-03
Pitch date: 2024-05-25
ABBV [bullish]
AbbVie Inc.
+46.81%
current return
Author Info
Disruptive Analytics has 30+ years of experience as a retail investor and is now fully engaged in managing their own money. Sign up for the newsletter.
Company Info
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
Market Cap
$368.4B
Pitch Price
$146.11
Price Target
188.47 (-12%)
Dividend
3.32%
EV/EBITDA
14.25
P/E
102.71
EV/Sales
6.88
Sector
Biotechnology
Category
value
AbbVie Inc. - $ABBV
ABBV: Strong portfolio & pipeline expand moat in arthritis, botox, oncology. Excels at M&A, bolstering neuroscience & next-gen cancer treatments. 20% upside despite bull run; massive FCF & dividend pay to wait for gains. Election may bring short-term healthcare jitters.
Read full article (3 min)